Didn't realize RX-3117 was in Phase 1 already,are you sure?This is the last news on RX 3117 I found: http://www.rexahn.com/cms/index.php/2012/05/rexahn-pharmaceuticals-announces-publication-of-new-preclinical-research-data-for-novel-anti-cancer-compound-rx-3117/